Journal article
Time to clinical investigation for indigenous and non-indigenous queensland women after a high grade abnormal pap smear, 2000-2009
LJ Whop, PD Baade, JML Brotherton, K Canfell, J Cunningham, D Gertig, K Lokuge, G Garvey, SP Moore, A Diaz, DL O’Connell, P Valery, DM Roder, JR Condon
Medical Journal of Australia | AUSTRALASIAN MED PUBL CO LTD | Published : 2017
DOI: 10.5694/mja16.00255
Abstract
Objectives: To investigate time to follow-up (clinical investigation) for Indigenous and non-Indigenous women in Queensland after a high grade abnormality (HGA) being detected by Pap smear. Design, setting, participants: Population-based retrospective cohort analysis of linked data from the Queensland Pap Smear Register (PSR), the Queensland Hospital Admitted Patient Data Collection, and the Queensland Cancer Registry. 34 980 women aged 20e68 years (including 1592 Indigenous women) with their first HGA Pap smear result recorded on the PSR (index smear) during 2000e2009 were included and followed to the end of 2010. Main outcome measures: Time from the index smear to clinical investigation (h..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The National Indigenous Cervical Screening Project is funded by a National Health and Medical Research Council (NHMRC) Project Grant (104559). This project is part of the NHMRC Centre of Research Excellence in Discovering Indigenous Strategies to Improve Cancer Outcomes via Engagement, Research Translation and Training (DISCOVER-TT CRE; 1041111) and the Cancer Council NSW Strategic Research Partnership to Improve Cancer Control for Indigenous Australians (STREP Ca-CIndA; SRP13-01). We also acknowledge the ongoing support of the Lowitja Institute, Australia's national institute for Aboriginal and Torres Strait Islander health research. Lisa Whop was supported by a Sidney Myer Health scholarship, a Menzies Enhanced Living scholarship, and a Lowitja Institute scholarship. Abbey Diaz was supported by an NHMRC postgraduate scholarship (1055587) and a DISCOVER-TT CRE-funded Menzies Enhanced Living scholarship. The NHMRC supported Joan Cunningham with a research fellowship (1058244), Patricia Valery with a career development fellowship (1083090), and Karen Canfell with a career development award (1082989). We acknowledge the staff and registrars from the Queensland Health Pap Smear Register, the Queensland Cancer Registry, and the Queensland Health Admitted Patient Data Collection for their assistance in providing the data, and the Queensland Research Linkage Group for linking the data. We gratefully acknowledge Tegan Harris for a range of contributions, including designing and building the database. The views expressed in this publication are those of the authors and do not necessarily reflect the views of the funding agencies.